|
|
|
Volumn 24, Issue 4, 1997, Pages 455-462
|
|
Management strategies for recurrent non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
EPIRUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
IRINOTECAN;
MITOMYCIN C;
NAVELBINE;
PACLITAXEL;
TOPOTECAN;
VINDESINE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RECURRENT CANCER;
REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
SURVIVAL RATE;
TAXOIDS;
TREATMENT FAILURE;
|
|
EID: 0030740432
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (70)
|
|
References (54)
|
